iBio, Inc. (IBIO) (CIK 0001420720) (IBIO)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Mar. 4, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Mar. 4, 2026 | CORRESP | Neutral/Informational | Moderate | iBio, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on February 27, 2026. They are seeking… | Read Filing EDGAR |
| Mar. 4, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to iBio, Inc. that it will not review their registration statement filed on February 27, 2026. This indicates that the SEC is not taking an active role in… | Read Filing EDGAR |
| Feb. 5, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to iBio, Inc. that it will not review the company's registration statement filed on January 30, 2026. The letter emphasizes that the responsibility for th… | Read Filing EDGAR |
| Feb. 5, 2026 | CORRESP | Neutral/Informational | Moderate | iBio, Inc. has submitted a request to the SEC to accelerate the effective date of its Registration Statement on Form S-3, originally filed on January 30, 2026. The company seeks t… | Read Filing EDGAR |